Acquisitions (Details) - Schedule of asset acquisition |
12 Months Ended |
---|---|
Dec. 31, 2022
USD ($)
| |
Schedule Of Asset Acquisition Abstract | |
2,700,000 shares of Pasithea common stock | $ 3,402,000 |
Warrants to acquire 1,000,000 shares of common stock at exercise price of $1.88 | 522,358 |
Cash | 1,000,000 |
Non-refundable payment for AlloMek transaction expenses | 50,000 |
Pasithea transaction expenses | 697,121 |
Total cost of asset acquisition | $ 5,671,479 |
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition Shares of pasithea common stock. No definition available.
|
X | ||||||||||
- Definition Warrants to acquire shares of common stock. No definition available.
|
X | ||||||||||
- Definition Amount of consideration transferred in asset acquisition. Includes, but is not limited to, cash, liability incurred by acquirer, and equity interest issued by acquirer. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Total costs of sales and operating expenses for the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Expenses recognized resulting from transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|